Researchers in the Department of Theoretical Physics at Tata Institute of Fundamental Research (TIFR), Mumbai, have discovered that instead of manipulating every component or modifying interactions in a many-body system, ...
Bioelectronics, such as implantable health monitors or devices that stimulate brain cells, are not as soft as the surrounding tissues due to their metal electronic circuits. A team of scientists from the University of Groningen ...
A team at McGill University studying ferroptosis, a form of cell death, have discovered that the process begins deep inside the cell, a finding that could lead to new treatments for cancer and neurodegenerative diseases.
When I first realized the scale of the challenge posed by neurodegenerative diseases, such as Alzheimer's, Parkinson's disease and amyotrophic lateral sclerosis (ALS), I felt simultaneously humbled and motivated. These disorders ...
For the first time, researchers have successfully fabricated and characterized a fully functional mirror-image nanopore—a molecular gateway built entirely from D-amino acids, the mirror-image forms of the natural building ...
Researchers have made a significant advance in the development of a blood test for Alzheimer's, creating a new sensor design that is ultra-sensitive, outperforms competing technologies and can be built into a handheld device.
A research team led by Prof. Ben Ko Chi-bun, Associate Professor of the PolyU Department of Applied Biology and Chemical Technology, has discovered the critical mechanism of action of tetrandrine, a compound derived from ...
Researchers from Tokyo Metropolitan University have developed a new structure determination method using nuclear magnetic resonance (NMR) spectroscopy which shows how different parts of complex molecular machinery like enzymes ...
In synthetic and structural biology, advances in artificial intelligence have led to an explosion of designing new proteins with specific functions, from antibodies to blood clotting agents, by using computers to accurately ...
An international workshop of scientists, regulators, and industry experts led by Prof Ivana Barbaric convened to address the risks of genetic mutations in stem cell therapy.
